Alliant Energy has been investing more capital into the business, but returns on that capital haven't increased. This potentially indicates that investors are accounting for this going forward. The company's investments don't seem to provide a high return on capital.
Alliant Energy's high ROE, boosted by significant debt, is concerning. The low ROE despite high debt is seen as a poor result. The company's ability to generate high returns on equity without excessive debt is crucial in evaluating its business quality.
Alliant Energy's high P/E ratio is worrisome considering its lower projected growth compared to the broader market. Investors retaining their stock may face future disappointment if the P/E drops to align with the growth outlook. The current high P/E and anticipated future earnings do not back the positive sentiment for long.
The company's steady but unimpressive ROCE and relatively small stock returns over the last five years do not inspire much confidence in its potential for massive growth. Given these trends, investors seeking high-earning opportunities might want to explore other options.
Alliant Energy, despite heavy reliance on debt, has a troubling lower ROE performance. Investors should consider factors beyond ROE, such as future profit growth and investment efforts, when comparing businesses.
Utility stocks were the clear stars of the$標普500指數(.SPX.US)$in Wednesday morning trading. The sector of the S&P 500 was up 0.8%. Health care was the only other of the index’s 11 sectors to trade in the green with a relatively modest 0.2% advance. The S&P 500 as a whole was down around 0.4%.Health care was the only other of the index’s 11 sectors to trade in the green with a relatively modest 0.2% advance. The S&P 500 as a whole was down around ...
Gapping up $聯合太平洋(UNP.US)$+9.5% (The company said CEO Lance Fritz would have a successor named this year. Bank of America upgraded the stock to buy from neutral following the news.) $Seagen(SGEN.US)$+14.9% (The Wall Street Journal reported that Pfizer is in talks to acquire the cancer drugmaker, which has a market value of about $30 billion.) $伯克希爾-B(BRK.B.US)$+0.32% (The company Saturday that its operating pro...
Norfolk Southern Upgraded to Outperform From Peer Perform at Wolfe Research Wolfe Research analyst Scott Group upgraded$諾福克南方(NSC.US)$to Outperform from Peer Perform with a $255 price target. The shares have underperformed since the Ohio derailment about two weeks ago, but the company's near-term trends look more favorable with volumes up 3% quarter-to-date, above expectations and best among the U.S. rails, the analyst tells...
美國聯合能源股票討論區
Utility stocks outperform in morning trading
The sector of the S&P 500 was up 0.8%. Health care was the only other of the index’s 11 sectors to trade in the green with a relatively modest 0.2% advance. The S&P 500 as a whole was down around 0.4%.Health care was the only other of the index’s 11 sectors to trade in the green with a relatively modest 0.2% advance.
The S&P 500 as a whole was down around ...
專欄Today's Pre-Market Stock Movers: LI, UNP, SGEN, BBY and More
$聯合太平洋(UNP.US)$ +9.5% (The company said CEO Lance Fritz would have a successor named this year. Bank of America upgraded the stock to buy from neutral following the news.)
$Seagen(SGEN.US)$ +14.9% (The Wall Street Journal reported that Pfizer is in talks to acquire the cancer drugmaker, which has a market value of about $30 billion.)
$伯克希爾-B(BRK.B.US)$ +0.32% (The company Saturday that its operating pro...
專欄US Top Rating Updates on 2/21: DOCU, NSC, CEG, MOS and More
Wolfe Research analyst Scott Group upgraded $諾福克南方(NSC.US)$ to Outperform from Peer Perform with a $255 price target. The shares have underperformed since the Ohio derailment about two weeks ago, but the company's near-term trends look more favorable with volumes up 3% quarter-to-date, above expectations and best among the U.S. rails, the analyst tells...
專欄Top upgrades and downgrades on 5/17
• $美國超微公司(AMD.US)$ : Piper Sandler Upgrades to Overweight from Neutral - PT $140 (from $98)
• $庫珀醫療(COO.US)$ : Citigroup Upgrades to Buy from Neutral - PT $405 (from $460)
• $資產住宅公司(EQR.US)$ : Mizuho Securities Upgrades to Buy from Neutral - PT $84 (from $92)
• $埃塞克斯信托(ESS.US)$ : Goldman Sachs Upgrades to Buy from Sell
• $烏龜海岸(HEAR.US)$ : Wedbush Upgrades to Outperform from Neutra...
暫無評論